Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.42 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11363078 | 1.00 | GPR84 (0.48) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL2818859 | 1.00 | GPR84 (0.48) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL15153583 | 1.00 | GPR84 (0.48) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL3501372 | 1.00 | GPR84 (0.48) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL8402045 | 1.00 | GPR84 (0.48) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL4977789 | 1.00 | GPR84 (0.48) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL5480087 | 0.98 | GPR84 (0.45) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL3501156 | 0.91 | — | — | |
| SCHEMBL15153431 | 0.83 | TSHR (0.54) | GPR84FFAR1FFAR4TSHRSPHK1 | |
| SCHEMBL19039336 | 0.83 | TSHR (0.54) | GPR84FFAR1FFAR4TSHRSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2203434-B1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI HOLDINGS CO LTD (KR) | 2012-08-29 | — | — | EP | disclosed |
| US-8242288-B2 | Method of preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method | HANMI HOLDINGS CO., LTD. (KR) | 2012-08-14 | — | — | US | disclosed |
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2010-10-28 | — | — | US | disclosed |
| EP-2203434-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | Hanmi Pharm. Co., Ltd. (KR) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009057938-A2 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5,6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | HANMI PHARM. CO., LTD. (KR) | 2009-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100274029-A1 | METHOD OF PREPARING (6R)-3-HEXYL-4-HYDROXY-6-UNDECYL-5, 6-DIHYDROPYRAN-2-ONE, AND INTERMEDIATE USED IN THE METHOD | DHCR7, DHPS, CYP8B1 | GPR84 4041/4885FFAR1 179/4885FFAR4 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.